Dr. Helena A. Yu

Dr. Helena Yu, MD, is a nationally recognized thoracic medical oncologist at Memorial Sloan Kettering Cancer Center (MSKCC), where she specializes in the care of patients with lung cancer. She holds the position of Associate Attending Physician and plays an integral role in advancing precision medicine initiatives for non-small cell lung cancer (NSCLC). Dr. Yu earned her medical degree from the University of Pennsylvania Perelman School of Medicine, completed her residency in internal medicine at Massachusetts General Hospital, and pursued fellowship training in medical oncology at MSKCC. She is board-certified in both internal medicine and medical oncology.

A leading expert in molecularly driven lung cancer, Dr. Yu focuses on developing and refining targeted therapies for patients with genetic alterations such as EGFR and ALK mutations. Her research examines mechanisms of resistance to tyrosine kinase inhibitors and evaluates novel agents through early-phase and investigator-initiated clinical trials. Dr. Yu has authored numerous peer-reviewed publications in top oncology journals and is a frequent presenter at international scientific meetings, contributing significantly to the evolution of lung cancer therapy.

Beyond her clinical and research endeavors, Dr. Yu is a committed educator and mentor, guiding the next generation of oncologists and clinical investigators. She collaborates with multidisciplinary teams to deliver personalized, evidence-based care, integrating cutting-edge science with compassionate treatment. Through her leadership in translational research and dedication to improving patient outcomes, Dr. Yu is a driving force in shaping the future of thoracic oncology.